Answer
Women of childbearing potential taking belumosudil mesilate (Rezurock) must have pregnancy status verified before starting treatment and use a reliable, highly effective contraceptive method throughout treatment and for at least one week after the last dose.
Sources for this answer
- REZUROCK 200 mg film-coated tablets.SANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked